# OnCo record adiuvo-2 (trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/trials/adiuvo-2/>
  a schema:MedicalTrial ;
  onco:kind "trial" ;
  schema:identifier "adiuvo-2", "NCT03583710" ;
  schema:name "ADIUVO-2"@en ;
  schema:alternateName "ADIUVO 2"@en, "ADIUVO-2 trial"@en ;
  schema:description "ADIUVO-2 tests whether adding platinum chemotherapy to mitotane after surgery lowers the high relapse rate of aggressive adrenal cancers; it is still recruiting through MD Anderson and the ENSAT network."@en ;
  schema:url <https://onco.cc/trials/adiuvo-2/> ;
  schema:dateModified "2026-09-22"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/study/NCT03583710> ;
  onco:status "recruiting" ;
  onco:tag "soc-trials" ;
  onco:phase "3" ;
  onco:cancers <https://onco.cc/cancers/localised-adrenocortical-carcinoma/>, <https://onco.cc/cancers/adrenocortical/> ;
  onco:technologies <https://onco.cc/technologies/cytotoxic-chemotherapy/> ;
  onco:drugs <https://onco.cc/drugs/mitotane/>, <https://onco.cc/drugs/cisplatin/>, <https://onco.cc/drugs/etoposide/> ;
  onco:institutions <https://onco.cc/institutions/md-anderson/> .